Price Alert

ImmunoGen Inc. (IMGN)

NASDAQ: IMGN · Real-Time Price · USD

31.23

0.00 (0.00%)

At close: Feb 09, 2024, 9:58 PM

ImmunoGen Statistics

Share Statistics

ImmunoGen has 279.35M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	279.35M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	247.85M
Failed to Deliver (FTD) Shares	132
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 20.61M, so 7.38% of the outstanding shares have been sold short.

Short Interest	20.61M
Short % of Shares Out	7.38%
Short % of Float	7.4%
Short Ratio (days to cover)	5

Valuation Ratios

The PE ratio is -5.64 and the forward PE ratio is 36.32. ImmunoGen's PEG ratio is 0.3.

PE Ratio	-5.64
Forward PE	36.32
PS Ratio	11.56
Forward PS	11.5
PB Ratio	8.07
P/FCF Ratio	-5.44
PEG Ratio	0.3

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ImmunoGen.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.1.

Current Ratio	2.26
Quick Ratio	2.5
Debt / Equity	0.1
Debt / EBITDA	-0.07
Debt / FCF	-0.07
Interest Coverage	-53.04

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$392.71K
Profits Per Employee	$-804.8K
Employee Count	277
Asset Turnover	0.31
Inventory Turnover	-0.01

Taxes

Income Tax	1.22M
Effective Tax Rate	-0.55%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.17, so ImmunoGen's price volatility has been higher than the market average.

Beta	1.17
52-Week Price Change	n/a
50-Day Moving Average	29.69
200-Day Moving Average	19.27
Relative Strength Index (RSI)	82.52
Average Volume (20 Days)	8,287,745

Income Statement

In the last 12 months, ImmunoGen had revenue of 108.78M and earned -222.93M in profits. Earnings per share was -0.88.

Revenue	108.78M
Gross Profit	108.61M
Operating Income	-220.89M
Net Income	-222.93M
EBITDA	-220.1M
EBIT	-217.55M
Earnings Per Share (EPS)	-0.88

Full Income Statement

Balance Sheet

The company has 275.14M in cash and 15.24M in debt, giving a net cash position of 259.89M.

Cash & Cash Equivalents	275.14M
Total Debt	15.24M
Net Cash	259.89M
Retained Earnings	-1.69B
Total Assets	822.1M
Working Capital	601.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -229.8M and capital expenditures -1.36M, giving a free cash flow of -231.17M.

Operating Cash Flow	-229.8M
Capital Expenditures	-1.36M
Free Cash Flow	-231.17M
FCF Per Share	-0.91

Full Cash Flow Statement

Margins

Gross margin is 99.84%, with operating and profit margins of -203.06% and -204.93%.

Gross Margin	99.84%
Operating Margin	-203.06%
Pretax Margin	-203.81%
Profit Margin	-204.93%
EBITDA Margin	-202.33%
EBIT Margin	-203.06%
FCF Margin	-212.5%

Dividends & Yields

IMGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for IMGN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	18.12
Piotroski F-Score	3